<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vavuranakis, Manolis</style></author><author><style face="normal" font="default" size="100%">Vrachatis, Dimitrios A</style></author><author><style face="normal" font="default" size="100%">Siasos, Gerasimos</style></author><author><style face="normal" font="default" size="100%">Vaina, Sophia</style></author><author><style face="normal" font="default" size="100%">Filis, Konstantinos</style></author><author><style face="normal" font="default" size="100%">Sigala, Fragiska</style></author><author><style face="normal" font="default" size="100%">Kalogeras, Konstantinos</style></author><author><style face="normal" font="default" size="100%">Kolokathis, Angelos-Michail</style></author><author><style face="normal" font="default" size="100%">Moldovan, Carmen</style></author><author><style face="normal" font="default" size="100%">Papaioannou, Theodore G</style></author><author><style face="normal" font="default" size="100%">Aggeli, Constantina</style></author><author><style face="normal" font="default" size="100%">Tousoulis, Dimitrios</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">First in Greece Transcatheter Aortic Valve Implantation using the CoreValve Evolut-R Retrievable and Repositionable Bioprosthesis with the InLine Sheath and the EnVeo Loading Guiding Catheter: A Major Advantage for SmallDiameter Access Vessels.</style></title><secondary-title><style face="normal" font="default" size="100%">Hellenic J Cardiol</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Hellenic J Cardiol</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Aged</style></keyword><keyword><style  face="normal" font="default" size="100%">Aortic Valve Stenosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Cardiac Catheterization</style></keyword><keyword><style  face="normal" font="default" size="100%">Comorbidity</style></keyword><keyword><style  face="normal" font="default" size="100%">Female</style></keyword><keyword><style  face="normal" font="default" size="100%">Femoral Artery</style></keyword><keyword><style  face="normal" font="default" size="100%">Greece</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Transcatheter Aortic Valve Replacement</style></keyword><keyword><style  face="normal" font="default" size="100%">Treatment Outcome</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015 Jul-Aug</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">56</style></volume><pages><style face="normal" font="default" size="100%">338-43</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">We report the first TAVI procedure in Greece to use the CoreValve Evolut-R (23 mm profile) bioprosthesis with the InLine sheath and the EnVeo loading guiding catheter in a patient with small anatomical characteristics (aortic annulus, access vessel) and severe comorbidities. The procedure was successfully conducted under general anesthesia through a surgically prepared, extensively calcified, left femoral artery.</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/26233775?dopt=Abstract</style></custom1></record></records></xml>